-
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns Overweight Rating from Piper Sandler
Source: Buzz FX / 08 Oct 2024 11:21:10 America/Chicago
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns Overweight Rating from Piper Sandler Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Arrowhead Pharmaceuticals ( NASDAQ:ARWR - Get Free Report ) 's stock had its "overweigh
Read more...